HIGHLIGHTS
- What: This studies have pointed out that, in addition to clinical necessary symptomatic first aid measures, favorable effects have also been reported for blockers targeting cytokines.
- Who: T-ALL and collaborators from the Azienda Ospedaliero Universitaria Policlinico San Marco, Italy RWTH Aachen University, Germany have published the article: Acute T-cell lymphoblastic leukemia: chimeric antigen receptor technology may offer a new hope, in the Journal: (JOURNAL)
- Future: While early results are encouraging more research and long-term data are necessary to make definitive conclusions about the long-term outcomes of CAR-T therapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.